We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Joseph and colleagues analyzed data from 1,570 adults ...

A new experimental drug lowered blood pressure and sharply reduced signs of kidney damage in people with chronic kidney ...

A drug that has been used to slow progression of kidney and cardiovascular disease in people with type 2 diabetes may also help people with chronic kidney disease who do not have diabetes, according ...

Higher serum aldosterone levels among patients with chronic kidney disease (CKD) are independently associated with an increased risk for CKD progression and end-stage kidney disease (ESKD) regardless ...

New drug Baxdrostat lowers stubborn high blood pressure in difficult-to-treat patients, showing promising results in a global ...

Researchers have linked higher levels of the hormone aldosterone to high blood pressure and blood vessel disease in African-Americans. Aldosterone is secreted by the adrenal glands and causes salt ...

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis. Studies have found that a variety of ways can lead to the ...

Aldosterone is a hormone that causes salt retention, which raises blood pressure. Some people have abnormally high aldosterone levels, but it's difficult to accurately assess aldosterone levels ...

Unusual Manifestation of an Aldosterone-Producing Adenoma Primary aldosteronism was first described by Jerome Conn in 1955 in a patient with an aldosterone-producing adrenal adenoma. It's now a widely ...

Although aldosterone has an essential role in controlling electrolyte and body fluid homeostasis, aldosterone also exerts certain pathological effects on the kidney. Several previous studies have ...

Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas (APAs)-adrenal gland tumors that drive high blood pressure. Using cutting-edge analysis ...